Study of Natural Course Progression of Diabetic Retinopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Natural Course Progression of Diabetic Retinopathy — Stella

Home/Biomarkers of Diabetic Retinopathy/

View on ClinicalTrials.gov

Recruiting

Back to Biomarkers of Diabetic Retinopathy trials

Trial locations(1 site)

China

Sichuan Academy of Medical Science Sichuan Provincial Hosptial, Chengdu, Sichuan

Key details

Sponsor

Jie Li

Enrollment target

~200 participants

Started

February 2024

Primary completion

January 2029

Age range

18 Years – 75 Years

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.